{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:48:40Z","timestamp":1786549720550,"version":"build-2736575974"},"reference-count":40,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Russian Ministry of Science and Education","award":["075-15-2022-301"],"award-info":[{"award-number":["075-15-2022-301"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Dev. Dis.","JCDD"],"abstract":"<jats:p>Genetic analysis of patients with lipid metabolism disorders is becoming increasingly prevalent in clinical practice. In particular, researchers are directing considerable attention toward studying familial hypercholesterolemia (FH). Despite its high population frequency (heterozygous FH occurs in approximately 1 in 250\u2013300 individuals, with even higher prevalence reported in some regions of the world), the heterogeneity of this condition presents major obstacles to its diagnosis. Owing to the advancement of molecular methods and laboratory technologies, it has become possible to establish the genetic basis of metabolic disorders. In the present study, using next-generation sequencing (NGS), a cohort of 261 patients with a confirmed clinical diagnosis of familial hypercholesterolemia was investigated. Among the 82 variants identified in FH-associated genes (LDLR, APOB, PCSK9, LDLRAP1), the most prevalent was the LDLR NP_000518.3:p.Leu401His variant, which was detected in 21 patients. The second most frequent variant in our cohort (19 patients) was APOB NP_000433.2:p.Arg3527Gln. Overall, 56.1% of patients with a DLCN score of 3\u20135 (possible FH) carried pathogenic variants, demonstrating the insufficient sensitivity of clinical criteria alone. The presence of early coronary heart disease in 22.73% of genotype-negative patients, together with the considerable number of individuals displaying a pronounced clinical FH phenotype despite negative genetic testing, underscores the importance of further exploring the genetic architecture of FH across different populations.<\/jats:p>","DOI":"10.3390\/jcdd13080384","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:45:06Z","timestamp":1786545906000},"page":"384","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic Spectrum of Familial Hypercholesterolemia in Russian North-West Registry: Focus on Correlation Between Clinical and Genetic Diagnosis"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8107-7572","authenticated-orcid":false,"given":"Maria I.","family":"Krivosheina","sequence":"first","affiliation":[{"name":"Institute of Molecular Biology and Genetics, Almazov National Medical Research Centre, 2 Akkuratova, Saint-Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4892-5497","authenticated-orcid":false,"given":"Viktoria V.","family":"Bakaleiko","sequence":"additional","affiliation":[{"name":"Department of Faculty Therapy, Almazov National Medical Research Centre, Saint-Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V.","family":"Reutova","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology and Genetics, Almazov National Medical Research Centre, 2 Akkuratova, Saint-Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina S.","family":"Sokolnikova","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology and Genetics, Almazov National Medical Research Centre, 2 Akkuratova, Saint-Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9349-6257","authenticated-orcid":false,"given":"Anna A.","family":"Kostareva","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology and Genetics, Almazov National Medical Research Centre, 2 Akkuratova, Saint-Petersburg 197341, Russia"},{"name":"Department of Faculty Therapy, Almazov National Medical Research Centre, Saint-Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asiiat S.","family":"Alieva","sequence":"additional","affiliation":[{"name":"Department of Faculty Therapy, Almazov National Medical Research Centre, Saint-Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/ATVBAHA.108.179564","article-title":"The LDL receptor","volume":"29","author":"Goldstein","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019: Update from the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Wiegman, A., Bourbon, M., Freiberger, T., Gidding, S.S., Greber-Platzer, S., Groselj, U., Holven, K.B., Hudgins, L.C., Humphries, S.E., and Hutten, B.A. (2026). Familial hypercholesterolaemia in children and adolescents: A European Atherosclerosis Society consensus statement. Eur. Heart J., 47.","DOI":"10.1093\/eurheartj\/ehag382"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"McGowan, M.P., Hosseini Dehkordi, S.H., Moriarty, P.M., and Duell, P.B. (2019). Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia. J. Am. Heart Assoc., 8.","DOI":"10.1161\/JAHA.119.013225"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MOL.0000000000000925","article-title":"Genetic testing for familial hypercholesterolemia","volume":"35","author":"Zhang","year":"2024","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1210\/jc.2015-3874","article-title":"The p.Leu167del Variant in APOE Gene Causes Autosomal Dominant Hypercholesterolemia by Down-regulation of LDL Receptor Expression in Hepatocytes","volume":"101","author":"Cenarro","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/joim.13577","article-title":"Genetic and molecular architecture of familial hypercholesterolemia","volume":"293","author":"Abifadel","year":"2023","journal-title":"J. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jacbts.2023.03.013","article-title":"High-Throughput Microscopy Characterization of Rare LDLR Variants","volume":"8","author":"Zimon","year":"2023","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/MOL.0000000000000734","article-title":"Recent advances in ABCG5 and ABCG8 variants","volume":"32","author":"Fong","year":"2021","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/cge.14185","article-title":"Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene","volume":"102","author":"Heidemann","year":"2022","journal-title":"Clin. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.amjcard.2008.06.056","article-title":"Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia","volume":"102","author":"Civeira","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2011.12.021","article-title":"Molecular characterization of familial hypercholesterolemia in Spain","volume":"221","author":"Palacios","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Olmastroni, E., Gazzotti, M., Averna, M., Arca, M., Tarugi, P., Calandra, S., Bertolini, S., Catapano, A.L., and Casula, M. (2023). Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia. J. Am. Heart Assoc., 12.","DOI":"10.1161\/JAHA.122.029223"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s12031-023-02139-6","article-title":"First LIPA Variant Analysis in Egyptian Patients Reveals One Novel Variant: Wolman Disease","volume":"73","author":"Elaraby","year":"2023","journal-title":"J. Mol. Neurosci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1093\/eurheartj\/ehaf581","article-title":"LIPA, a risk locus for coronary artery disease: Decoding the variant-to-function relationship","volume":"46","author":"Li","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCRESAHA.115.304660","article-title":"Variants in STAP1 are associated with autosomal dominant hypercholesterolemia","volume":"115","author":"Fouchier","year":"2014","journal-title":"Circ. Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Alves, M., Laranjeira, F., and Correia-da-Silva, G. (2024). Understanding Hypertriglyceridemia: Integrating Genetic Insights. Genes, 15.","DOI":"10.3390\/genes15020190"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1194\/jlr.M088203","article-title":"Genetic and secondary causes of severe HDL deficiency and cardiovascular disease","volume":"59","author":"Geller","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"911","DOI":"10.5551\/jat.RV22037","article-title":"Cholesteryl Ester Transfer Protein Deficiency and Hyperalphalipoproteinemia","volume":"32","author":"Inazu","year":"2025","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"102687","DOI":"10.1016\/j.jacadv.2026.102687","article-title":"TNFR Pathway-Related Proteins and Recurrent Coronary Artery Disease Events","volume":"5","author":"Lee","year":"2026","journal-title":"JACC Adv."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Xu, Y., Gong, W., Peng, J., Wang, H., Huang, J., Ding, H., and Wang, D.W. (2014). Functional analysis LRP6 novel variants in patients with coronary artery disease. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0084345"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.gim.2021.09.012","article-title":"ClinGen Familial Hypercholesterolemia Expert Panel. The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification","volume":"24","author":"Chora","year":"2022","journal-title":"Genet. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jacl.2025.02.016","article-title":"Investigation of the genetic background of familial hypercholesterolemia in a Turkish cohort and its clinical implications","volume":"19","year":"2025","journal-title":"J. Clin. Lipidol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Timoshchenko, O., Ivanoshchuk, D., Semaev, S., Orlov, P., Zorina, V., and Shakhtshneider, E. (2023). Diagnosis of Familial Hypercholesterolemia in Children and Young Adults. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010314"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Meshkov, A., Ershova, A., Kiseleva, A., Zotova, E., Sotnikova, E., Petukhova, A., Zharikova, A., Malyshev, P., Rozhkova, T., and Blokhina, A. (2021). The LDLR, APOB, and PCSK9 Variants of Index Patients with Familial Hypercholesterolemia in Russia. Genes, 12.","DOI":"10.3390\/genes12010066"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41598-020-58734-9","article-title":"Variant type classification and pathogenicity assignment of sixteen missense variants located in the EGF-precursor homology domain of the LDLR","volume":"10","author":"Uribe","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MOL.0000000000000937","article-title":"APOE and familial hypercholesterolemia","volume":"35","author":"Civeira","year":"2024","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"783","DOI":"10.5551\/jat.RV17024","article-title":"Sitosterolemia, Hypercholesterolemia, and Coronary Artery Disease","volume":"25","author":"Tada","year":"2018","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MED.0000000000000316","article-title":"Familial dysbetalipoproteinemia: An underdiagnosed lipid disorder","volume":"24","author":"Koopal","year":"2017","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/eurjpc\/zwaa451","article-title":"Next-generation sequencing to confirm clinical familial hypercholesterolemia","volume":"28","author":"Reeskamp","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/cge.14036","article-title":"Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement","volume":"100","author":"Giacobbe","year":"2021","journal-title":"Clin. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Fularski, P., Hajdys, J., Majchrowicz, G., Stabrawa, M., M\u0142ynarska, E., Rysz, J., and Franczyk, B. (2024). Unveiling Familial Hypercholesterolemia-Review, Cardiovascular Complications, Lipid-Lowering Treatment and Its Efficacy. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031637"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1038\/s41598-018-20281-9","article-title":"New Sequencing technologies help revealing unexpected variants in Autosomal Dominant Hypercholesterolemia","volume":"8","author":"Elbitar","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients with Severe Hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamacardio.2019.5954","article-title":"Association of Monogenic vs. Polygenic Hypercholesterolemia with Risk of Atherosclerotic Cardiovascular Disease","volume":"5","author":"Trinder","year":"2020","journal-title":"JAMA Cardiol."}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/8\/384\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:57:06Z","timestamp":1786546626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/8\/384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcdd13080384"],"URL":"https:\/\/doi.org\/10.3390\/jcdd13080384","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]}}}